Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» efimosfermin alfa
efimosfermin alfa
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
BioSpace
Wed, 05/14/25 - 09:46 am
GSK
Boston Pharmaceuticals
efimosfermin alfa
MASH
Boston Pharma hits phase 2 MASH goal, positioning monthly prospect to follow Akero, 89bio into pivotal trials
Fierce Biotech
Fri, 11/15/24 - 11:17 am
Boston Pharmaceuticals
clinical trials
MASH
efimosfermin alfa